CRTX.L

CRISM Therapeutics Corporation CRTX.L

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CRTX.L ROQ.L TCF.L MHC.L CIZ.L FUM.L FDBK.L N4P.L TRX.L VAL.L
6M 15.79 % 2.70 % -6.67 % -50.00 % 3.33 % -76.56 % -41.53 % 60.00 % -76.65 % 5.00 %
YTD 4.76 % -54.76 % -60.00 % -44.00 % -3.13 % -93.06 % -44.80 % 14.29 % -85.47 % -30.00 %
1Y 29.41 % -50.65 % -68.42 % -50.00 % -27.91 % -93.45 % -80.29 % 0.00 % -84.26 % -75.58 %
3Y -95.70 % -75.48 % -95.28 % -70.83 % -3.13 % -94.50 % -89.38 % -80.95 % -82.47 % -96.56 %
5Y -97.02 % -71.85 % -98.50 % -45.10 % -83.47 % -84.70 % -94.83 % -91.37 % -77.33 % -98.09 %
10Y -99.99 % -71.85 % -99.39 % -99.17 % -83.47 % -91.57 % -98.10 % -80.00 % -99.50 % -99.98 %
From the beginning -100.00 % -71.85 % -99.39 % -100.00 % -83.47 % -96.93 % -99.93 % -99.96 % -99.62 % -100.00 %

Dividend

CRISM Therapeutics Corporation

Feedback plc

N4 Pharma Plc